Stock listing
Stockholm:ONCO Oncopeptides AB Aktie
Home listing (Stockholm) of Oncopeptides AB
Follow Oncopeptides AB into a list and get an email when it puts out news.
Share price · OMXSTO:ONCO
1.67 SEK -0.04 (-2.2%)
Close on Oct 30, 2026
- Day range
- 1.67 – 1.74 SEKOct 30, 2026
- Volume
- 2.87M sharesOct 30, 2026
- Market cap
- 638.0M SEKAt the close on Oct 30, 2026 · price × 381.4M shares outstanding
- 52-week range
- 1.26 – 5.79 SEKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- 10.47M SEKMedian day 2.37M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:ONCO · Home | 1.673 SEK | -0.038 (-2.2%) | 2,872,967 | 1.711 | 1.741 | 1.67 | 1.711 | Close on Oct 30, 2026 |
| Frankfurt:OND | €0.154 EUR | +0.010 (+6.7%) | — | €0.154 | €0.154 | €0.154 | €0.145 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXSTO:ONCO · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 1.673 | -0.038 | -2.2% | 1.711 | 1.741 | 1.67 | 2,872,967 | |
| 1.711 | +0.051 | +3.1% | 1.652 | 1.76 | 1.642 | 5,103,183 | |
| 1.66 | 0.00 | 0.0% | 1.67 | 1.67 | 1.639 | 2,007,726 | |
| 1.66 | -0.01 | -0.6% | 1.685 | 1.686 | 1.619 | 2,799,081 | |
| 1.67 | -0.02 | -1.2% | 1.691 | 1.747 | 1.67 | 2,267,792 | |
| 1.69 | +0.032 | +1.9% | 1.667 | 1.696 | 1.631 | 3,654,430 | |
| 1.658 | -0.032 | -1.9% | 1.70 | 1.721 | 1.63 | 2,537,730 | |
| 1.69 | -0.038 | -2.2% | 1.732 | 1.74 | 1.679 | 2,045,977 | |
| 1.728 | -0.01 | -0.6% | 1.745 | 1.767 | 1.684 | 3,550,813 | |
| 1.738 | -0.039 | -2.2% | 1.80 | 1.812 | 1.717 | 3,820,556 | |
| 1.777 | +0.03 | +1.7% | 1.76 | 1.86 | 1.741 | 5,174,772 | |
| 1.747 | -0.053 | -2.9% | 1.792 | 1.818 | 1.702 | 10,182,892 | |
| 1.80 | -0.524 | -22.5% | 2.05 | 2.05 | 1.79 | 44,815,784 | |
| 2.324 | -0.102 | -4.2% | 2.44 | 2.52 | 2.308 | 8,173,790 | |
| 2.426 | -0.538 | -18.2% | 3.048 | 3.18 | 2.32 | 26,820,338 | |
| 2.964 | +0.922 | +45.2% | 2.042 | 3.04 | 2.012 | 29,221,704 | |
| 2.042 | -0.028 | -1.4% | 2.088 | 2.088 | 2.00 | 1,359,900 | |
| 2.07 | +0.018 | +0.9% | 2.10 | 2.226 | 2.062 | 5,652,825 | |
| 2.052 | -0.008 | -0.4% | 2.088 | 2.174 | 2.042 | 2,190,792 | |
| 2.06 | -0.046 | -2.2% | 2.11 | 2.13 | 2.042 | 1,496,694 | |
| 2.106 | -0.056 | -2.6% | 2.198 | 2.228 | 2.106 | 2,262,233 | |
| 2.162 | -0.024 | -1.1% | 2.186 | 2.238 | 2.13 | 2,595,414 | |
| 2.186 | -0.068 | -3.0% | 2.26 | 2.304 | 2.15 | 3,205,625 | |
| 2.254 | -0.136 | -5.7% | 2.394 | 2.394 | 2.20 | 3,768,998 | |
| 2.39 | -0.11 | -4.4% | 2.51 | 2.592 | 2.374 | 4,254,335 | |
| 2.50 | +0.196 | +8.5% | 2.338 | 2.56 | 2.336 | 5,378,112 | |
| 2.304 | -0.13 | -5.3% | 2.42 | 2.42 | 2.294 | 2,958,634 | |
| 2.434 | -0.076 | -3.0% | 2.51 | 2.64 | 2.37 | 10,250,955 | |
| 2.51 | +0.398 | +18.8% | 2.21 | 2.51 | 2.164 | 14,637,544 | |
| 2.112 | +0.046 | +2.2% | 2.12 | 2.256 | 2.09 | 7,222,735 | |
| 2.066 | +0.326 | +18.7% | 1.969 | 2.272 | 1.966 | 18,871,699 | |
| 1.74 | +0.07 | +4.2% | 1.681 | 1.799 | 1.681 | 2,368,590 | |
| 1.67 | +0.045 | +2.8% | 1.64 | 1.672 | 1.63 | 594,044 | |
| 1.625 | +0.005 | +0.3% | 1.633 | 1.661 | 1.62 | 726,045 | |
| 1.62 | -0.02 | -1.2% | 1.64 | 1.661 | 1.612 | 629,396 | |
| 1.64 | +0.01 | +0.6% | 1.626 | 1.658 | 1.615 | 1,115,481 | |
| 1.63 | -0.034 | -2.0% | 1.664 | 1.685 | 1.621 | 1,532,997 | |
| 1.664 | -0.024 | -1.4% | 1.698 | 1.70 | 1.653 | 1,141,953 | |
| 1.688 | -0.059 | -3.4% | 1.736 | 1.779 | 1.68 | 2,192,629 | |
| 1.747 | -0.033 | -1.9% | 1.78 | 1.784 | 1.731 | 1,621,780 | |
| 1.78 | -0.109 | -5.8% | 1.902 | 1.939 | 1.767 | 3,624,326 | |
| 1.889 | -0.006 | -0.3% | 1.937 | 1.979 | 1.858 | 2,702,423 | |
| 1.895 | +0.025 | +1.3% | 1.90 | 1.969 | 1.88 | 1,384,536 | |
| 1.87 | -0.04 | -2.1% | 1.93 | 1.99 | 1.841 | 2,189,356 | |
| 1.91 | -0.118 | -5.8% | 2.02 | 2.02 | 1.841 | 4,132,557 | |
| 2.028 | -0.022 | -1.1% | 2.06 | 2.156 | 1.95 | 8,473,388 | |
| 2.05 | +0.348 | +20.4% | 1.742 | 2.10 | 1.731 | 22,539,223 | |
| 1.702 | +0.05 | +3.0% | 1.652 | 1.736 | 1.645 | 1,777,960 | |
| 1.652 | +0.007 | +0.4% | 1.666 | 1.68 | 1.60 | 2,560,720 | |
| 1.645 | -0.031 | -1.8% | 1.685 | 1.716 | 1.645 | 1,376,295 | |
| 1.676 | -0.068 | -3.9% | 1.751 | 1.751 | 1.67 | 1,871,471 | |
| 1.744 | -0.015 | -0.9% | 1.771 | 1.858 | 1.721 | 3,232,272 | |
| 1.759 | +0.06 | +3.5% | 1.729 | 1.76 | 1.68 | 1,886,521 | |
| 1.699 | -0.012 | -0.7% | 1.709 | 1.743 | 1.657 | 3,825,757 | |
| 1.711 | +0.133 | +8.4% | 1.587 | 1.789 | 1.585 | 9,261,888 | |
| 1.578 | +0.008 | +0.5% | 1.572 | 1.60 | 1.568 | 1,040,140 | |
| 1.57 | -0.013 | -0.8% | 1.582 | 1.628 | 1.551 | 2,118,624 | |
| 1.583 | -0.011 | -0.7% | 1.608 | 1.608 | 1.571 | 1,220,832 | |
| 1.594 | +0.004 | +0.3% | 1.586 | 1.61 | 1.581 | 1,099,820 | |
| 1.59 | -0.012 | -0.7% | 1.592 | 1.602 | 1.583 | 689,377 | |
| 1.602 | -0.003 | -0.2% | 1.60 | 1.64 | 1.596 | 1,742,802 | |
| 1.605 | +0.007 | +0.4% | 1.61 | 1.614 | 1.594 | 697,451 | |
| 1.598 | -0.002 | -0.1% | 1.587 | 1.626 | 1.587 | 1,149,125 | |
| 1.60 | +0.03 | +1.9% | 1.58 | 1.619 | 1.562 | 1,109,773 | |
| 1.57 | -0.012 | -0.8% | 1.592 | 1.60 | 1.561 | 886,314 | |
| 1.582 | -0.002 | -0.1% | 1.594 | 1.61 | 1.573 | 2,173,408 | |
| 1.584 | -0.021 | -1.3% | 1.615 | 1.615 | 1.58 | 814,103 |
- Ticker
- Stockholm:ONCO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stockholm
- Currency
- SEK
What changed lately
Latest news release · May 26, 2026
Oncopeptides signs agreement with Salus for distribution and commercialization of Pepaxti in Central and Eastern Europe
Latest earnings call · Aug 27, 2026
Oncopeptides (Stockholm:ONCO) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 27, 2026
Q2 2026 Earnings Presentation
Earnings · 34 slides
Calls
Replays
Oncopeptides (Stockholm:ONCO) Q2 2026 Earnings Call
Thu, Aug 27, 2026 · 3:00 AM ET
Watch TranscriptOncopeptides (Stockholm:ONCO) Q1 2026 Earnings Call
Wed, May 13, 2026 · 3:00 AM ET
Watch TranscriptOncopeptides (Stockholm:ONCO) Q4 2025 Earnings Call
Thu, Feb 19, 2026 · 3:00 AM ET
Watch Transcript
Latest news
Oncopeptides signs agreement with Salus for distribution and commercialization of Pepaxti in Central and Eastern Europe
May 26, 2026
Closed 1.87 (+8.5%) on May 26, 2026
Oncopeptides (Q1 Update): Strong Quarterly Growth and Decreased Costs
May 20, 2026
Closed 1.95 (+2.4%) on May 20, 2026
Oncopeptides secures regulatory approval to start Window-of-Opportunity study in glioblastoma from Norwegian authorities
May 19, 2026
Closed 1.95 (+2.4%) on May 20, 2026
Oncopeptides publishes Q1 report 2026
May 13, 2026
Closed 1.77 (+38.7%) on May 13, 2026
Oncopeptides intends to submit type II variation to expand Pepaxti label to include third line treatment
May 11, 2026
Closed 1.28 (+1.0%) on May 11, 2026
Invitation to presentation of the Q1 report 2026
May 6, 2026
Closed 1.29 (-2.5%) on May 6, 2026
Oncopeptides publishes the 2025 Annual Report
Apr 28, 2026
Closed 1.31 (-4.4%) on Apr 29, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 34 slides · Aug 27, 2026
Type II application Investor conference (May 2026)
Conference · 29 slides · May 11, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 60 slides · May 2026
Q4 2025 Earnings Presentation
Earnings · 26 slides · Feb 19, 2026
Oncopeptides AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 7 in the last 12 months · 7 in all · newest May 26, 2026 · oldest 2026
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 27, 2026
- Decks
- 13 decks · latest Aug 27, 2026
Where Oncopeptides AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:ONCO · Home listing · This page | Stockholm | Sweden | SEK |
| LS Exchange:A2DLU2 | LS Exchange | Germany | EUR |
| LSIN:0RN4 | LSIN | United Kingdom | SEK |
| gettex:OND | gettex | Germany | EUR |
| Aquis:ONCOS | Aquis | United Kingdom | SEK |
| Lang & Schwarz:A2DLU2 | Lang & Schwarz | Germany | EUR |
| Stuttgart:OND | Stuttgart | Germany | EUR |
| Aquis:ONCOS | Aquis | United Kingdom | SEK |
| Dusseldorf:OND | Dusseldorf | Germany | EUR |
| Frankfurt:OND | Frankfurt | Germany | EUR |
| Turquoise:ONCOS | Turquoise | United Kingdom | SEK |
| Munich:OND | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Oncopeptides AB.